Cargando…

2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析

OBJECTIVE: To investigate the microbiologic and clinical characteristics of bloodstream infection in neutropenic pediatric patients with hematological malignancies and provide data support for the rational use of antimicrobial agents in these patients. METHODS: A retrospective analysis was performed...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525167/
https://www.ncbi.nlm.nih.gov/pubmed/32942819
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.08.007
_version_ 1783588688209379328
collection PubMed
description OBJECTIVE: To investigate the microbiologic and clinical characteristics of bloodstream infection in neutropenic pediatric patients with hematological malignancies and provide data support for the rational use of antimicrobial agents in these patients. METHODS: A retrospective analysis was performed on the clinical data, pathogen species distribution, and drug sensitivity data of bloodstream infection in neutropenic pediatric patients with hematological malignancies from the Institute of Hematology & Blood Diseases Hospital from January 2014 to December 2018. RESULTS: Total 537 episodes of bloodstream infections occurred in 427 neutropenic children with hematological malignancies; the 30-day all-cause mortality rate was 3.7%. The clinical feature of 44.7% patients with bloodstream infection was only fever, and the pathogenic bacteria were mainly enterobacteriaceae bacteria. Bloodstream infection was usually accompanied by oral mucosa (20.7%), respiratory tract (20.5%), and digestive tract (14.3%) symptoms. The distribution of pathogens in patients with different symptoms of bloodstream infection varied (χ(2)=40.561, P=0.001). Total 550 strains of pathogens were isolated, and the top 5 bacteria were Streptococcus aureus (109 strains, 19.8%), Escherichia coli (99 strains, 18.0%), Staphylococcus epidermidis (75 strains, 13.6%), Klebsiella pneumoniae (67 strains, 12.2%), and Staphylococcus aureus (32 strains, 5.8%). The resistance rates of Enterobacteriaceae and Pseudomonas aeruginosa to piperacillin/tazobactam and carbapenems were <5%. The proportion of methicillin-resistant Staphylococcus aureus (MRSA) in Staphylococcus aureus was 9.7%. CONCLUSION: The proportion of pathogenic bacteria gram-positive cocci and gram-negative bacilli in the bloodstream infection of neutropenic children with hematological malignancies was approximately the same, suggesting that the use of antimicrobial agents should be broad-spectrum. Carbapenems, glycopeptides, and enzyme inhibitor complexes still have good effects.
format Online
Article
Text
id pubmed-7525167
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-75251672020-09-30 2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To investigate the microbiologic and clinical characteristics of bloodstream infection in neutropenic pediatric patients with hematological malignancies and provide data support for the rational use of antimicrobial agents in these patients. METHODS: A retrospective analysis was performed on the clinical data, pathogen species distribution, and drug sensitivity data of bloodstream infection in neutropenic pediatric patients with hematological malignancies from the Institute of Hematology & Blood Diseases Hospital from January 2014 to December 2018. RESULTS: Total 537 episodes of bloodstream infections occurred in 427 neutropenic children with hematological malignancies; the 30-day all-cause mortality rate was 3.7%. The clinical feature of 44.7% patients with bloodstream infection was only fever, and the pathogenic bacteria were mainly enterobacteriaceae bacteria. Bloodstream infection was usually accompanied by oral mucosa (20.7%), respiratory tract (20.5%), and digestive tract (14.3%) symptoms. The distribution of pathogens in patients with different symptoms of bloodstream infection varied (χ(2)=40.561, P=0.001). Total 550 strains of pathogens were isolated, and the top 5 bacteria were Streptococcus aureus (109 strains, 19.8%), Escherichia coli (99 strains, 18.0%), Staphylococcus epidermidis (75 strains, 13.6%), Klebsiella pneumoniae (67 strains, 12.2%), and Staphylococcus aureus (32 strains, 5.8%). The resistance rates of Enterobacteriaceae and Pseudomonas aeruginosa to piperacillin/tazobactam and carbapenems were <5%. The proportion of methicillin-resistant Staphylococcus aureus (MRSA) in Staphylococcus aureus was 9.7%. CONCLUSION: The proportion of pathogenic bacteria gram-positive cocci and gram-negative bacilli in the bloodstream infection of neutropenic children with hematological malignancies was approximately the same, suggesting that the use of antimicrobial agents should be broad-spectrum. Carbapenems, glycopeptides, and enzyme inhibitor complexes still have good effects. Editorial office of Chinese Journal of Hematology 2020-08 /pmc/articles/PMC7525167/ /pubmed/32942819 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.08.007 Text en 2020年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析
title 2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析
title_full 2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析
title_fullStr 2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析
title_full_unstemmed 2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析
title_short 2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析
title_sort 2014–2018年儿童恶性血液病患者中性粒细胞缺乏期血流感染病原学和临床特征分析
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525167/
https://www.ncbi.nlm.nih.gov/pubmed/32942819
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.08.007
work_keys_str_mv AT 20142018niánértóngèxìngxuèyèbìnghuànzhězhōngxìnglìxìbāoquēfáqīxuèliúgǎnrǎnbìngyuánxuéhélínchuángtèzhēngfēnxī
AT 20142018niánértóngèxìngxuèyèbìnghuànzhězhōngxìnglìxìbāoquēfáqīxuèliúgǎnrǎnbìngyuánxuéhélínchuángtèzhēngfēnxī
AT 20142018niánértóngèxìngxuèyèbìnghuànzhězhōngxìnglìxìbāoquēfáqīxuèliúgǎnrǎnbìngyuánxuéhélínchuángtèzhēngfēnxī
AT 20142018niánértóngèxìngxuèyèbìnghuànzhězhōngxìnglìxìbāoquēfáqīxuèliúgǎnrǎnbìngyuánxuéhélínchuángtèzhēngfēnxī
AT 20142018niánértóngèxìngxuèyèbìnghuànzhězhōngxìnglìxìbāoquēfáqīxuèliúgǎnrǎnbìngyuánxuéhélínchuángtèzhēngfēnxī
AT 20142018niánértóngèxìngxuèyèbìnghuànzhězhōngxìnglìxìbāoquēfáqīxuèliúgǎnrǎnbìngyuánxuéhélínchuángtèzhēngfēnxī
AT 20142018niánértóngèxìngxuèyèbìnghuànzhězhōngxìnglìxìbāoquēfáqīxuèliúgǎnrǎnbìngyuánxuéhélínchuángtèzhēngfēnxī
AT 20142018niánértóngèxìngxuèyèbìnghuànzhězhōngxìnglìxìbāoquēfáqīxuèliúgǎnrǎnbìngyuánxuéhélínchuángtèzhēngfēnxī